Clinical Trial Detail

NCT ID NCT03603964
Title Guadecitabine Extension Study
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications

acute myeloid leukemia

myelodysplastic syndrome

Advanced Solid Tumor

Therapies

Guadecitabine

Age Groups: adult senior

No variant requirements are available.